Solace Biotech Limited, a active public limited company, was established on 22 July 2013 in Saha, Haryana, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24232HR2013PLC049887. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹3.00 M.
It upholds a compliant status. Employing 10 professional, Its leadership includes Kamal Chawla (Director), Raman Chawla (Director), Rohit Gupta (Director). Past directors included Chhatrapal Singh Rajput, Satish Kumar, Rohit Gupta. It holds ₹9.05 Cr open charges and ₹5.61 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. 195, Sector-2 Phase-1, Food Park, Industrial Estate, Saha, Haryana, 133104.
U24232HR2013PLC049887
049887
22 July 2013
₹3.00 M
₹3.00 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Solace Biotech Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kamal Chawla | Director | 22 Jul 2013 | Current |
| Raman Chawla | Director | 22 Jul 2013 | Current |
| Rohit Gupta | Director | 24 Dec 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 14 Sep 2015 | Past |
| Pramod Abcsdd | Director | 26 Dec 2022 | Past |
| Pramod Abcsdd | Director | 22 Feb 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Solace Biotech Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 27% decrease. The company also saw a substantial fall in profitability, with a 48.89% decrease in profit. The company's net worth moved up by a moderate rise of 1.83%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Solace Biotech had a promoter holding of 99.77% and a public holding of 0.23%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹90,450,888.00
₹56,084,501.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 May 2025 | Others | ₹3.85 Cr | Open |
| 22 Dec 2022 | Others | ₹3.20 M | Open |
| 22 Dec 2022 | Others | ₹1.75 M | Open |
| 22 Dec 2022 | Others | ₹2.62 M | Open |
| 22 Dec 2022 | Others | ₹3.70 Cr | Open |
Explore comprehensive loan charge details -
Solace Biotech has a workforce of 10 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Solace Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Solace Biotech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others of Rs. 38.50 M registered on 27 May 2025 with Charge ID 101108269 was modified on 25 Jul 2025. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 38.50 M with Charge ID 101108269 was registered on 27 May 2025. was documented.
Solace Biotech Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Solace Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
The activity A charge registered on 18 Mar 2021 via Charge ID 100429377 with Others was fully satisfied on 20 Feb 2024. was completed.
The activity A charge registered on 08 Feb 2021 via Charge ID 100417943 with Others was fully satisfied on 20 Feb 2024. was completed.
The CIN of Solace Biotech Limited is U24232HR2013PLC049887.
Solace Biotech Limited is headquartered at Plot No. 195, Sector-2 Phase-1, Food Park, Industrial Estate, Saha, Haryana, 133104.
Solace Biotech Limited was incorporated on 22 July 2013.
The current directors of Solace Biotech Limited are
The primary industry of Solace Biotech Limited is Trade.
Solace Biotech Limited is unlisted.
The authorized capital of Solace Biotech Limited is ₹3.00 M, and the paid-up capital is ₹3.00 M.
The compliance status of Solace Biotech Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX